Methods Materials GSH, GSSG, 2-mercaptoethanol, ophthalmic acid, S -methylglutathione and yeast glutathione reductase (GR) were obtained from Sigma-Aldrich, HEDS was from Alfa Aesar, GSSCys from Toronto Research Chemicals and NADPH was from Gerbu
Parkinsons therapies in the clinical trial pipeline: a 10-year retrospective analysis A special edition of our annual clinical trial report has now been published in the Journal of Parkinsons Disease (JPD), providing an overview of the Parkinsons clinical trial landscape from 2015 to 2024
Main Indications : memory and concentration support, cognitive function in seniors, mental fatigue, neuroprotection
Nevertheless, effective therapies to impact the pathogenesis and progression of DPN are lacking